Current through September 9, 2024
(a) Any pharmacy that accepts for return drug
products dispensed to correctional institutions, pursuant to section 27 of
Public Act No. 01-9, June Special Session, shall comply with the requirements
of this section.
(b) A pharmacy
shall not accept for return any drug products that do not meet the criteria for
return under section 27 of Public Act No. 01-9, June Special Session.
(c) A pharmacy shall physically inspect all
drug products that are returned by correctional institutions. Any drug products
in original manufacturer's dispensing packages that have been opened, have had
doses removed, or show any signs of tampering shall not be returned to stock.
Any drug products packaged in unit dose or blister type packaging that appear
to have been removed from and returned to the dispensing package, or drug
products in such packaging that appears to have been tampered with or the
integrity of which appears to be compromised in any way, shall not be returned
to stock, except as permitted in subsection (d)(2) of this section.
(d) Except as provided in subsections (b) and
(c) of this section, a pharmacy may return to stock for re-dispensing drug
products:
(1) packaged in original
manufacturer's dispensing packages;
(2) packaged in unit dose or blister type
packaging whose individual labeling and integrity remains intact even though
doses may have been removed from the outer package; or
(3) originally packaged by the pharmacy into
multiple dose blister packaging. Except as otherwise permitted by this
subdivision, such drug products shall be removed from the original dispensing
package before being placed into pharmacy stock for re-dispensing. This process
shall be done in a manner that insures that the lot number and expiration date
for the drug product are maintained and that the individual doses of the drug
product are not exposed to possible adulteration or cross-contamination.
Generically equivalent drug products from more than one drug manufacturer shall
not be co-mingled. Removal of the drug product from the original dispensing
package prior to re-dispensing shall not be required for packaging from which
no doses have been removed and for packaging that allows disassembly without
handling the drug product, while maintaining product identification, lot
number, and expiration date.
(e)
(1) All
drug products re-dispensed on prescription from the pharmacy shall be labeled
with all required information, including lot number and expiration
date.
(2) The expiration date
assigned to the drug product for re-dispensing shall be no later than the
expiration date assigned to the product when originally dispensed, or no later
than the earliest expiration date originally assigned to any dose contained in
the repackaged multiple dose blister card dispensed.
(3) The lot number assigned shall be the
manufacturer's original lot number for products dispensed in manufacturers'
original packaging, or a lot number assigned by the pharmacy for a repackaged
product, from which the original lot numbers of the doses contained may be
referenced.
